Skip to main content
SpringerLink
Log in

Dementia with Lewy Bodies

  • Chapter
Neuropsychiatric Disorders

  • 1495 Accesses

Abstract

Dementia with Lewy bodies (DLB) has over the last two decades become recognised as a common dementia subtype in older people. Since it shares clinical and pathological features with both Alzheimer’s disease and Parkinson’s disease, knowledge of DLB is essential not only in its own right, but also to obtain a full understanding of its two prototypical boundary disorders. This chapter reviews what is currently known about the clinical, pathological and management aspects of DLB.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 47:1113–1124

    Article  PubMed  CAS  Google Scholar 

  2. Kosaka K, Yoshimura IK et al (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree – a new disease? Clin Neuropathol 3(5):185–192

    PubMed  CAS  Google Scholar 

  3. Gibb WRG, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110:1131–1153

    Article  PubMed  Google Scholar 

  4. Hansen L, Salmon D, Galasko D et al (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology 40:1–8

    Article  PubMed  CAS  Google Scholar 

  5. Perry RH, Irving D, Blessed G et al (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95:119–139

    Article  PubMed  CAS  Google Scholar 

  6. Byrne EJ, Lennox G, Godwin-Austen LB et al (1991) Dementia associated with cortical Lewy bodies. Proposed diagnostic criteria. Dementia 2:283–284

    Google Scholar 

  7. McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 65:1863–1872

    Article  PubMed  CAS  Google Scholar 

  8. McKeith I, Del Ser T, Spano P et al (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 356:2031–2036

    Article  PubMed  CAS  Google Scholar 

  9. McKeith I, Fairbairn A, Perry R et al (1992) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 305:673–678

    Article  CAS  Google Scholar 

  10. Ballard C, Grace J, McKeith I et al (1998) Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer’s disease. Lancet 351:1032–1033

    Article  PubMed  CAS  Google Scholar 

  11. Molloy S, McKeith IG, O’Brien JT et al (2005) The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 76:1200–1203

    Article  PubMed  CAS  Google Scholar 

  12. Rahkonen T, Eloniemi-Sulkava U, Rissanen S et al (2003) Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 74(6):720–724

    Article  PubMed  CAS  Google Scholar 

  13. Shergill S, Mullen E, D’Ath P et al (1994) What is the clinical prevalence of Lewy body dementia? Int J Geriatr Psychiatry 9:907–912

    Article  Google Scholar 

  14. Stevens T, Livingston G, Kitchen G et al (2002) Islington study of dementia subtypes in the community. Br J Psychiatry 180:270–276

    Article  PubMed  Google Scholar 

  15. Holmes C, Cairns N, Lantos P et al (1999) Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174:45–51

    Article  PubMed  CAS  Google Scholar 

  16. Singleton AB, Wharton A, O’Brien KK et al (2002) Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dement Geriatr Cogn Disord 14:167–175

    Article  PubMed  CAS  Google Scholar 

  17. Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355–363

    PubMed  CAS  Google Scholar 

  18. Gómez-Tortosa E, Newall K, lrizarry MC et al (1999) Clinical and quantitative pathological correlates of dementia with Lewy bodies. Neurology 53:1284–1291

    Article  PubMed  Google Scholar 

  19. Parkkinen L, Kauppinen T, Pirttilä T et al (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57:82–91

    Article  PubMed  CAS  Google Scholar 

  20. Zaccai J, Brayne C, McKeith I et al (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042–1048

    Article  PubMed  CAS  Google Scholar 

  21. Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27:1405–1410

    Article  PubMed  CAS  Google Scholar 

  22. Perry EK, Piggott MA, Johnson M et al (2003) Neurotransmitter correlates of neuropsychiatric symptoms in dementia with Lewy bodies. In: Bedard M-A, Agid Y, Chouinard S et al (eds) Mental and behavioral dysfunction in movement disorders. Humana, Totowa, NJ, pp. 285–294

    Google Scholar 

  23. Hamilton RL (2000) Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378–384

    Article  PubMed  CAS  Google Scholar 

  24. Lippa CF, McKeith I (2003) Dementia with Lewy bodies: improving diagnostic criteria. Neurology 60:1571–1572

    Article  PubMed  Google Scholar 

  25. Uchikado H, Lin WL, DeLucia M et al (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697

    Article  PubMed  CAS  Google Scholar 

  26. Singleton A, Gwinn-Hardy K (2004) Parkinson’s disease and dementia with Lewy bodies: a difference in dose? Lancet 364(9440):1105–1107

    Article  PubMed  Google Scholar 

  27. Johnson J, Hague SM, Hanson M et al (2004) SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 63(3):554–556

    Article  PubMed  CAS  Google Scholar 

  28. Clark LN, Kartsaklis LA, Wolf Gilbert R et al (2009) Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol 66:578–583

    Article  PubMed  Google Scholar 

  29. Hardy J, Lewis P, Revesz T et al (2009) The genetics of Parkinson’s syndromes: a critical review. Curr Opin Genet Dev 19:254–265

    Article  PubMed  CAS  Google Scholar 

  30. Ballard C, O’Brien J, Morris CM et al (2001) The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer’s disease. Int J Geriatr Psychiatry 16(5):499–503

    Article  PubMed  CAS  Google Scholar 

  31. Walker Z, Allen RL, Shergill S et al (2000) Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry 15:267–273

    Article  PubMed  CAS  Google Scholar 

  32. Hanyu H, Sato T, Hirao K et al (2009) Differences in clinical course between dementia with Lewy bodies and Alzheimer’s disease. Eur J Neurol 16:212–217

    Article  PubMed  CAS  Google Scholar 

  33. Armstrong TP, Hansen LA, Salmon DP et al (1991) Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer’s disease. Neurology 41:1178–1180

    Article  PubMed  CAS  Google Scholar 

  34. Aarsland D, Ballard C, McKeith I et al (2001) Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 13:374–379

    Article  PubMed  CAS  Google Scholar 

  35. Burn DJ, Rowan EN, Minett T et al (2003) Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord 18(8):884–889

    Article  PubMed  Google Scholar 

  36. Ballard C, O’Brien J, Swann A et al (2000) One year follow-up of parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord 11:219–222

    Article  PubMed  CAS  Google Scholar 

  37. Duda JE, Giasson BI, Mabon ME et al (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52(2):205–210

    Article  PubMed  CAS  Google Scholar 

  38. Walker MP, Ayre GA, Cummings JL et al (2000) The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry 177:252–256

    Article  PubMed  CAS  Google Scholar 

  39. Ballard CG, Mohan RNC, Patel A et al (1993) Idiopathic clouding of consciousness – do the patients have cortical Lewy body disease? Int J Geriatr Psychiatry 8:571–576

    Article  Google Scholar 

  40. Bradshaw J, Saling M, Hopwood M et al (2004) Fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease is qualitatively distinct. J Neurol Neurosurg Psychiatry 75:382–387

    Article  PubMed  CAS  Google Scholar 

  41. Ferman T, Smith GE, Boeve BF et al (2004) DLB fluctuations: specific features that reliably differentiate from AD and normal aging. Neurology 62(2):181–187

    Article  PubMed  CAS  Google Scholar 

  42. Mosimann UP, Rowan EN, Partington CE et al (2006) Characteristics of visual hallucinations in Parkinson disease dementia and dementia with Lewy bodies. Am J Geriatr Psychiatry 14(2):153–60

    Article  PubMed  Google Scholar 

  43. Birkett DP, Desouky A, Han L et al (1992) Lewy bodies in psychiatric patients. Int J Geriatr Psychiatry 7:235–240

    Article  Google Scholar 

  44. Boeve BF, Silber MH, Ferman TJ (2004) REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17(3):146–157

    Article  PubMed  Google Scholar 

  45. Klatka LA, Louis ED, Schiffer RB (1996) Psychiatric features in diffuse Lewy body disease: findings in 28 pathologically diagnosed cases. Neurology 46:A180

    Google Scholar 

  46. Ballard C, Shaw F, McKeith I et al (1998) High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 51:1760–1762

    Article  PubMed  CAS  Google Scholar 

  47. Del-Ser T, Munoz DG, Hachinski V (1996) Temporal pattern of cognitive decline and incontinence is different in Alzheimer’s disease and diffuse Lewy body disease. Neurology 46:682–686

    Article  PubMed  CAS  Google Scholar 

  48. McKeith I, Mintzer J, Aarsland D et al (2004) Dementia with Lewy bodies. Lancet Neurol 3:19–28

    Article  PubMed  Google Scholar 

  49. Mollenhauer B, Cullen V, Kahn I et al (2008) Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213(2):315–25

    Article  PubMed  CAS  Google Scholar 

  50. Burton EJ, Barber R, Mukaetova-Ladinska et al (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from in dementia with Lewy bodies and vascular cognitive impairment. Brain 132:195–203

    Article  PubMed  CAS  Google Scholar 

  51. Lobotesis K, Fenwick JD, Phipps A et al (2001) Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56:643–649

    Article  PubMed  CAS  Google Scholar 

  52. O’Brien JT, Paling S, Barber R et al (2001) Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 56(10):1386–1388

    Article  PubMed  Google Scholar 

  53. Walker Z, Costa DC, Ince P et al (1999) In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet 354:646–647

    Article  PubMed  CAS  Google Scholar 

  54. McKeith I, O’Brien J, Walker Z et al (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305–313

    Article  PubMed  Google Scholar 

  55. O’Brien JT, McKeith IG, Walker Z et al (2009) Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 194:34–39

    Article  PubMed  Google Scholar 

  56. Emre M (2003) Dementia associated with Parkinson’s disease. Lancet Neurol 2(4):229–237

    Article  PubMed  CAS  Google Scholar 

  57. Aarsland D, Andersen K, Larsen JP et al (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60(3):387–392

    Article  PubMed  Google Scholar 

  58. Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707

    Article  PubMed  Google Scholar 

  59. Ballard CG, Aarsland D, McKeith I et al (2002) Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 59(11):1714–1720

    Article  PubMed  CAS  Google Scholar 

  60. Aarsland D, Ballard C, Larsen JP et al (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 16:528–536

    Article  PubMed  CAS  Google Scholar 

  61. McKeith I (2007) Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide. Pract Neurol 7:374–382

    Article  PubMed  CAS  Google Scholar 

  62. McKeith I (2009) Commentary: DLB and PDD: the same or different? Is there a debate? Int Psychogeriatr 21:220–224

    Article  PubMed  Google Scholar 

  63. McKeith IG (2004) Dementia with Lewy bodies (DLB) and other difficult diagnoses. Int Psychogeriatr 16(2):123–127

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wolfson Research Centre, Institute for Ageing and Health, Campus for Ageing and Vitality,Newcastle University, Newcastle upon Tyne, NE4 5PL, UK

    Ian Grant McKeith

Authors
  1. Ian Grant McKeith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian Grant McKeith .

Editor information

Editors and Affiliations

  1. Jinmeikai Research Institute for Mental Health, 53-20 Kabutoyama-cho, Nishinomiya, Hyogo, 662-0001, Japan

    Koho Miyoshi M.D., Ph.D. (Director, The former Professor) & Yasushi Morimura M.D., Ph.D. (Chief Executive Officer) (Director, The former Professor) &  (Chief Executive Officer)

  2. Ohmura Hospital, 200 Kitayama-Ohmura, Miki, Hyogo, 673-0404, Japan

    Koho Miyoshi M.D., Ph.D. (Director, The former Professor) (Director, The former Professor)

  3. Department of Occupational Therapy, Kobe Gakuin University School of Rehabilitation, 518 Ikawadani-cho, Nishi-ku, Kobe, 651-2180, Japan

    Kiyoshi Maeda M.D., Ph.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer

About this chapter

Cite this chapter

McKeith, I.G. (2010). Dementia with Lewy Bodies. In: Miyoshi, K., Morimura, Y., Maeda, K. (eds) Neuropsychiatric Disorders. Springer, Tokyo. https://doi.org/10.1007/978-4-431-53871-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-53871-4_18

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-53870-7

  • Online ISBN: 978-4-431-53871-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation